Overview

Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte Membranopathies

Status:
Not yet recruiting
Trial end date:
2026-12-15
Target enrollment:
Participant gender:
Summary
This is a prospective exploratory multicentre pilot study designed to study the safety and efficacy of mitapivat in RBC membranopathies and CDAII
Phase:
Phase 2
Details
Lead Sponsor:
EuroBloodNet Association
Treatments:
Mitapivat